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Influenza-Associated Myositis in Children
P. Agyeman, A. Duppenthaler, U. Heininger, C. Aebi
Abstract
Background: Influenza-associated myositis (IAM) is an
infrequent and poorly known complication of influenza virus
infection in children. The aim of this study was to describe
five cases of IAM and to review the literature on IAM in
children. 
Patients and Methods: We conducted a retrospective
analysis of cases of IAM diagnosed at two university
children’s hospitals in Switzerland during two consecutive
influenza seasons. Findings were compared with 39
individual case reports and five publications summarizing an
additional 272 cases identified by a medical online library
(MEDLINE) search. 
Results: Overall, 316 cases were analyzed. IAM typically
occurred in school-aged children with a 2:1 male
predominance. Influenza B and A viruses were identified in
76% and 24% of cases, respectively. The median interval
between onset of influenza and onset of IAM was 3 days
(range 0–18). The calf muscles were involved alone or
together with other muscle groups in 69% and 31% of cases,
respectively. Blood creatine phosphokinase (CPK)
concentration was invariably elevated. Median duration to
clinical recovery was 3 days (range 1–30). Rhabdomyolysis
occurred in ten of 316 patients (3%), was more common in
girls (80%), more often associated with influenza A (86%),
and led to renal failure in eight patients (80%). 
Conclusion: Clinical and laboratory findings of IAM are
highly characteristic and allow a rapid diagnosis during the
influenza season. 
Infection 2004; 32: 199–203
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Introduction
Influenza is a common and usually benign viral respiratory
tract infection occurring worldwide in annual epidemics
during the cold season. According to established medical
knowledge, complications are mainly seen in the elderly.
Recent studies, however, indicate that influenza-associated
morbidity in children may be greater than previously
thought [1, 2]. Complications mainly affect the respiratory
tract and the central nervous system.Another complication
of influenza, which has only sporadically been reported
since its first description in 1957 [3], is influenza-associated
myositis (IAM). IAM appears to be more common in chil-
dren than in adults, but its age-specific incidence during in-
fluenza epidemics is unknown. As IAM has typically been
associated with the influenza B virus, its incidence may de-
pend on the nature of circulating strains during a given epi-
demic.
There is no standardized nomenclature of IAM in the
literature and the pathogenetic events leading to muscle in-
volvement have not been elucidated in detail. Nevertheless,
both the clinical presentation and laboratory characteris-
tics of IAM seem fairly typical. Clinical manifestations can
be dramatic and IAM often causes diagnostic confusion be-
cause it is a poorly known entity in the medical community.
Although IAM usually follows a benign and self-limiting
course, several cases with a severe course and life-threat-
ening complications have been reported.
The aim of this study was to review recent experiences
with IAM at two large pediatric hospitals in Switzerland
and to review the medical literature.
Patients and Methods
Definitions 
IAM was defined as follows:Virologically proven influenza or in-
fluenza-like illness plus clinical evidence for localized myalgia plus
elevation of serum creatine phosphokinase (CPK) or abnormal
muscle biopsy in a patient younger than 16 years of age.The term
“rhabdomyolysis” was reserved arbitrarily for patients who also
had myoglobinuria.
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Patients
Medical records from children with IAM, who were seen at the
University Children’s Hospitals of Bern or Basel, Switzerland, dur-
ing the influenza seasons in 2002 and 2003, were analyzed.The fol-
lowing set of clinical data was retrieved for each patient: age, gen-
der, reason for referral, duration and characteristics of influenza
or influenza-like illness, muscle symptoms, other symptoms and
signs, laboratory parameters at presentation (i.e. peripheral white
blood cell count, serum C-reactive protein, CPK, aspartate
transaminase (ASAT), alanine transaminase (ALAT), creatinine,
and urinalysis), duration and course of illness, and outcome.
Laboratory Detection of Influenza Virus
Nasopharyngeal secretions (NPS) were sampled using a Vygon in-
fant mucus aspirator (Ecouen, France) and assessed for the pres-
ence of influenza A and B using a direct immunofluorescence as-
say (Light Diagnostics Respiratory Panel DFA, Chemicon Inter-
national, Inc., Temecula, CA, USA) or by a multiplex polymerase
chain reaction (PCR).This method was designed to amplify cDNA
specific for influenza A and B, respiratory syncytial virus (RSV),
parainfluenza virus types 1 and 3, and adenovirus.Viral RNA was
purified from NPS by use of the QIAamp Viral RNA kit (Qiagen,
Basel, Switzerland), and cDNA was synthesized by means of re-
verse transcriptase PCR (Titan One Tube RT-PCR System, Roche,
Basel, Switzerland). Multiplex PCR was performed in two sepa-
rate assays. One assay contained specific primers for influenza A,
influenza B, and parainfluenza virus type 1. Amplification prod-
ucts were sequenced.
Review of the Literature
A medical online library (MEDLINE) search using the keywords
influenza and muscle or myositis or rhabdomyolysis was per-
formed.Additional reports were retrieved using the reference lists
of papers identified by MEDLINE. Reports written in English,
French and German were considered. In 39 cases of IAM, case de-
scriptions provided sufficient detail to allow entry into the data-
base. This group of cases was named the reference group and was
compared to large case series which lacked individual patient data.
Results
Our Cases
We identified five patients with IAM (Table 1). Private pe-
diatricians referred four patients, one patient with severe
calf pain presented to the emergency room. In four patients,
the reason for referral was incapacitating calf pain. Sus-
pected diagnoses were Guillain-Barré syndrome in three
patients, deep venous thrombosis in one, and cerebellar
ataxia in one. The median age was 8.3 years (range
7.3–10.3). All patients had a history of a recent influenza-
like illness starting 2 to 5 days before presentation and con-
sisting of fever and rhinorrhea.Additional complaints were
sore throat, nausea, cough, and headache in patient 1, cough
in patient 2, and headache and dizziness in patient 4. In pa-
tients referred by their private physician, muscle symptoms
had started 1 to 2 days before presentation. Patient 3 pre-
sented on the day myalgia had started.The median interval
between the onset of influenza and the onset of muscle
symptoms was 2.5 days (range 0–4).
During clinical examination, all patients were afebrile,
had normal vital signs, and appeared non-toxic. No in-
fluenza-associated respiratory signs were present in pa-
tients 3 and 4. Rhinitis was observed in patients 1, 2 and 5.
Pharyngitis was observed in patient 1. The predominant
clinical manifestation in all patients was severe pain and lo-
calized tenderness of the calf muscles bilaterally, which led
to abnormal gait or refusal to walk. Neurologic examina-
tion was normal. There was no gross hematuria. IAM was
suspected in all patients and confirmation was achieved by
demonstrating massively elevated serum CPK concentra-
tions. Myoglobinuria was found in patient 4. Influenza virus
infection was documented in four patients by demonstra-
tion of influenza A or B virus in NPS. Two patients were
hospitalized briefly. All patients had a favorable outcome.
No complications or sequelae were recorded.
Review of the Literature
We identified 311 cases of IAM [3–36].Ten patients had re-
current episodes [3, 4, 17, 18, 34]. Of 294 patients in whom
the gender was noted, 200 were male, resulting in a gender
ratio of 2:1. Detailed data were available from the refer-
ence group consisting of 39 patients (Table 2). The median
age was 8.5 years (range 2.5–14). Lundberg [3] reported a
median age of 9 years, Mackay et al. [34] and Farrell et al.
[17] found a mean age of 8.1 and 7 years, respectively. In the
reference group, the median interval between the onset of
influenza-associated symptoms and the onset of muscle
symptoms was 3 days (range 0–18). Lundberg [3], Mackay
et al. [34] and Farrell et al. [17] found a median interval of
2.6, 5 and 5 days, respectively. In the reference group the
most frequent influenza-associated symptom was fever
(74%), followed by cough (33%), rhinorrhea (26%), nau-
sea and vomiting (23% each). Lundberg [3] recorded fever
in 92%, headache in 80%, and rhinitis and cough in 49%
and 46%, respectively. Nausea and vomiting were present
in 41%. In the reference group, muscle pain was located ex-
clusively in the lower extremities in 69%, particularly in the
calf muscles. Involvement of the upper extremities occurred
in 20% of cases and was always accompanied by lower ex-
tremity involvement. Four patients (10%) experienced gen-
eralized myalgia and in two cases (5%) paraspinal muscles
were involved [16, 25]. Refusal to walk and gait abnormal-
ities occurred in ten (26%) and 11 (28%) patients, respec-
tively. Clinical examination revealed tenderness of affected
muscles (74%) as the most frequent finding besides muscle
pain. Soft tissue edema was present in five children (13%).
Mackay et al. [34] found refusal to walk in 19%, with the
remaining 81% showing gait abnormalities. In the reference
group, the duration of muscle symptoms ranged from 1 to
30 days (median 3 days). Lundberg [3] and Middleton et al.
[4] reported a mean duration of 3 days. Farrell et al. [17]
noted that recovery took 3 to five days. CPK was deter-
mined in 36 patients listed in the reference group (median
4,100 U/l; range 230- > 106). Overall, CPK was measured in
230 of 311 cases and was elevated in 219 (95%). Serum lac-
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tic dehydrogenase (LDH) and aspartate transaminase
(AST) were also frequently elevated. Virologic analyses
performed in 190 cases yielded influenza B in 100 cases, in-
fluenza A in 31, and other viruses in 11. In one child, the
type of influenza virus was not specified. In 47 cases the re-
sult was negative.
Clinical course and outcome were mostly benign, but
ten of 311 reported children (3%) developed severe rhab-
domyolysis [9, 14, 23, 25, 27, 31–33,36].The median age was
9.3 years (range 3–14). In contrast to uncomplicated cases
of IAM, which had a male predominance of 2:1 and usually
affected the lower extremities, influenza-associated rhab-
domyolysis occurred more often in girls (4:1), and pain and
tenderness were mostly diffuse. Gross hematuria and myo-
globinuria were recorded in five and nine patients, respec-
tively. Viral studies were performed in seven cases (in-
fluenza A in six cases, influenza B in one). Eight patients
had acute renal failure [9, 23, 27, 31–33, 36]. This condition
resolved completely in all but one patient [23], but inten-
sive care management with temporary dialysis was neces-
sary in six cases. Two patients [27, 36] suffered from com-
partment syndrome and underwent fasciotomy, which left
one patient with a permanent walking disability. Two pa-
tients [9, 36] required artificial ventilation. One patient [23]
with familial carnitine palmitoyl-transferase deficiency
died.
Discussion
The first description of IAM as a clinically distinct entity
dates from 1957, when Lundberg [3] reported 70 children
and four adults with what he called “myalgia cruris epi-
demica.”This report has remained the largest collection of
cases of IAM in the literature. Lundberg postulated a viral
etiology based on clinical and epidemiologic data, but nei-
ther virologic analyses, nor blood CPK determinations were
performed. Middleton et al. [4] were the first to provide lab-
oratory evidence in support of an association with influenza
virus infection, which was demonstrated in 21 of 26 cases
described. Elevated CPK levels were found in 14 of 21 vi-
rologicaly confirmed cases.
Since then, cases with similar clinical and laboratory
findings were reported from different parts of the world.
The muscle affection was mostly named myositis, although
it is still unclear whether an inflammatory infiltrate justify-
ing the term myositis is usually present. Blood CPK is al-
most invariably elevated and indicates muscle damage, but
biopsy results are rarely compatible with frank myositis.
The largest series of biopsies in children with IAM was pre-
sented by Bove et al. [37]. Eleven of 12 biopsy specimens
showed patchy necrosis with little inflammatory infiltration,
and one specimen showed no changes at all. Overall, we
identified 35 reports of muscle biopsies in children with
IAM. Of these, 28 specimens [5, 8, 14, 17, 18, 23, 34, 36, 37]
had shown evidence of muscle degeneration and necrosis.
Inflammatory infiltrates were found in five specimens only
[5, 14, 18, 37]. Six specimens [3, 9, 12, 16, 37] showed no or
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unspecific changes.Thus, muscle necrosis rather than myosi-
tis is the most common finding. In mild IAM, the muscle is
mostly affected in a patchy pattern, contrasting with the
more severe influenza-associated rhabdomyolysis, in which
generalized necrosis may occur. Consequently, some 
authors have suggested that the term myopathy should be
used, rather than myositis.
While epidemiologic, clinical and laboratory data es-
tablish a firm link between influenza virus infection and
IAM, the mechanisms by which the virus leads to muscle
involvement are poorly understood. The two most com-
monly proposed mechanisms are direct muscle invasion by
viral particles and immune-mediated muscle damage trig-
gered by the virus.The hypothesis of direct muscle invasion
received support by findings of Bove et al. [37], who isolated
the influenza virus from a muscle biopsy specimen in a child
with IAM, and also by the reports of Gamboa et al. [38] and
Kessler et al. [39] who both isolated influenza virus from
muscle specimens from adults with IAM. Additionally,
Gamboa et al. [38] demonstrated myxovirus-like particles
by muscle electron microscopy. Experimental studies
[40–42] established that influenza virus is capable of in-
fecting both animal and human muscle cells, with immature
muscle cells being more permissive to infection than ma-
ture cells. This finding may explain the occurrence of IAM
predominantly in children.A difference in muscle infectiv-
ity between influenza A and influenza B has not been es-
tablished. Servidei et al. [42] proposed that a glycoprotein
unique to influenza B may render the virus more myotropic
than influenza A, but this hypothesis awaits experimental
confirmation.
Immune mechanisms have not been investigated in de-
tail. Early occurrence of IAM in the course of influenza and
the absence of inflammatory infiltrates argue against an im-
portant role of an immune-mediated process. Risk factors
for IAM brought forward in the literature include muscle
tropism of specific influenza virus strains [35], male gender
[35], and primary infection [10, 18, 24, 35] with an influenza
virus.
The present compilation of cases draws a clear picture
of the clinical presentation of IAM. It is a mostly benign
complication, which mainly affects muscles of the lower ex-
tremities and appears when the symptoms of influenza are
about to resolve. School-aged children are usually affected.
Myalgia may be severe, appears with an abrupt onset and
leads to gait abnormalities or refusal to walk for several
days. Muscle swelling and tenderness may occur. An im-
portant differential diagnostic feature is the absence of neu-
rological signs, although the reluctance of the child to use
the painful extremity can mimic muscle weakness. Labora-
tory investigations should include blood CPK determina-
tion, which is almost invariably elevated, and virologic stud-
ies. Most alternative diagnoses can be readily excluded.
Nonspecific myalgia is less severe and occurs at the climax
of influenza infection. Guillain-Barré syndrome is associ-
ated with absent tendon reflexes. Arthritis is frequently
asymmetric in distribution and CPK values are normal.
Dermatomyositis is characterized by a subtle onset, chronic
course and involvement of the skin. Deep venous throm-
bosis is an exceedingly rare condition in otherwise healthy
children. It usually involves one extremity only and can be
confirmed by Doppler sonography and determination of
blood D-dimers.
If muscle pain, swelling, and tenderness worsen rapidly
or the condition does not resolve within a few days, addi-
tional investigations of urine and renal parameters are in-
dicated. If rhabdomyolysis occurs, inpatient monitoring is
indicated for early recognition and treatment of complica-
tions such as acute renal failure, electrolyte disturbances, or
compartment syndrome. Watanabe et al. [43] recently ob-
served that rhabdomyolysis is the most frequently reported
cause of renal injury in children with influenza A infection.
Rhabdomyolysis has been reported more frequently in girls
C. Aebi et al. Influenza-Associated Myositis
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Parameter Value No. of patients 
with data
available
Median age (years) [range] 8.5 [2.5–14] 39
Male gender (%) 26 (67) 39
Median interval (days) [range]a 3 [0–18] 30
Location of muscle pain
Lower extremities (%) 27 (69) 39
Lower and upper 
extremities (%) 8 (20) 39
Generalized (%) 4 (10) 39
Median creatine 
phosphokinase (U/l) [range] 4,100 [230–
1,000,000] 36
Detection of influenza 
virus infection
Influenza A (%) 12 (80) 15b
Influenza B (%) 3 (20) 15b
Myoglobinuria 9 (56) 16
Major complications
Rhabdomyolysis (%) 9 (23) 39c
Renal failure (%) 8 (21) 39c
Compartment syndrome (%) 3 (8) 39c
Death 1 (3) 39c
No complication (%) 28 (72) 39c
Median duration to recovery 
(days)[range] 3 [1–30] 25
a interval between the onset of influenza-like illness and the on-
set of symptoms associated with IAM; b diagnosis was made by
serology and detection of virus in ten and five cases; c the total
number of complications listed exceeds the number of patients,
because some patients suffered from more than one complica-
tion
Table 2
Case characteristics of 39 children with influenza-associated
myositis (IAM) reported in the literature.
than in boys (4:1), and was mostly associated with influenza
A infection. Thus, although influenza-associated rhab-
domyolysis is rare, it should be considered in all patients
with IAM and clinical follow-up should be ascertained.
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